Abstract:Objective: Endovascular and hybrid methods have been increasingly used to treat mesenteric ischemia. However, the long-term outcomes and risk of symptom recurrence remain unknown. The objective of the present study was to define the predictors of postoperative morbidity, mortality, and patency loss for acute mesenteric ischemia (AMI) and chronic mesenteric ischemia (CMI). Methods: The inpatient and follow-up records for all patients who had undergone revascularization for AMI and CMI from 2010 to 2020 at a multicenter hospital system were reviewed. Patency and mortality were evaluated with Cox regression, visualized with Kaplan-Meier curves, and compared using log-rank testing. Patency was further evaluated using Fine-Gray regression with death as a competing risk. The postoperative major adverse events (MAE) and 30-day mortality were evaluated with logistic regression. Results: A total of 407 patients were included, 148 with AMI and 259 with CMI. For the AMI group, the 30-day mortality was 31%. Open surgery was associated with lower rates of bowel resection (odds ratio [OR], 0.23; 95% confidence interval [CI], 0.13-0.61). The etiology of AMI also did not change the outcomes (OR, 1.30; 95% CI, 0.77-2.19). Adjusted analyses indicated that a history of diabetes (OR, 2.77; 95% CI, 1.37-5.61) and sepsis on presentation (OR, 2.32; 95% CI, 1.18-4.58) were independently associated with an increased risk of 30-day MAE. In the CMI group, open surgery and chronic kidney disease were associated with a higher incidence of MAE (OR, 3.03; 95% CI, 1.14-8.05; OR, 2.37; 95% CI, 1.31-4.31). In contrast, chronic kidney disease (OR, 3.02; 95% CI, 1.10-8.37) and inpatient status before revascularization (OR, 2.78; 95% CI, 1.01-7.61) were associated with increased 30-day mortality. For the CMI group, the endovascular cohort had experienced greater rates of symptom recurrence (29% vs 13%) with a faster onset (endovascular, 64 days; vs bypass, 338 days). Conclusions: AMI remains a morbid disease despite the evolving revascularization techniques. An open approach should remain the reference standard because it reduces the likelihood of bowel resection. For CMI, endovascular interventions have improved the postoperative morbidity but have also resulted in early symptom recurrence and reintervention. An endovascular-first approach should be the standard of care for CMI with close surveillance.

Ischemic bowel disease in 2021

Differentiation of Isolated Small Bowel Crohn's Disease from Other Small Bowel Ulcerative Diseases: Clinical Features and Double-Balloon Enteroscopy Characteristics.

Endovascular Treatment of Spontaneous Isolated Dissection of the Superior Mesenteric Artery

Ischemic Colitis: Current Diagnosis and Treatment

Clinical features and treatments of ischemia bowel diseases

ISCHEMIC BOWEL DISEASE IN THE ELDERLY

Large Bowel Ischemia/Infarction: How to Recognize It and Make Differential Diagnosis? A Review

Chronic ischaemic bowel diseases in the aged—go with the flow

Acute and chronic mesenteric ischemia: single center analysis of open, endovascular, and hybrid surgery

Insights into acute mesenteric ischaemia: an up-to-date, evidence-based review from a mesenteric stroke centre unit

Contemporary management of acute and chronic mesenteric ischemia: 10-year experience from a multihospital healthcare system

Acute mesenteric ischemia: guidelines of the World Society of Emergency Surgery

Chronic Mesenteric Ischemia – Surgical and Interventional Options in Therapy

Acute and Chronic Ischemic Disorders of the Small Bowel

Endovascular Management for Symptomatic Chronic Mesenteric Ischemia: A Single-Center Experience.

The diagnosis and treatment of ischemic bowel disease, experience in 73 cases

Isolated Superior Mesenteric Artery Dissection: A Novel Etiology and a Review

Ischemic proctitis: case series and literature review

Chronic Mesenteric Ischemia: Diagnosis and Treatment

Navigating the Gut-Cardiac Axis: Understanding Cardiovascular Complications in Inflammatory Bowel Disease